Renowned health benefits provider UnitedHealth Group (UNH - Free Report) is set to report quarterly results Friday before the opening bell. UnitedHealth Group, a Zacks Rank #3 (Hold), has a robust history of exceeding earnings estimates. But as stocks have been volatile lately, is this market leader a buy heading into the Q2 earnings announcement?
Shares of UNH are up 1.37% this year, widely outperforming the major indices. Analysts are expecting the company to post Q2 EPS of $5.24 per share, which would translate to 11.49% growth versus the same quarter last year.
UnitedHealth Group has surpassed earnings estimates in every quarter for the past five years running. This long string of success suggests another earnings beat may be in store for investors. UNH has delivered a trailing four-quarter average earnings beat of 3.73%.
UNH is part of the Zacks Medical – HMOs industry, which ranks in the top 26% out of approximately 250 industry groups. The company pays a $6.60 (1.32%) annual dividend. UNH stock has really held up well this year while the market has corrected, and investors would be wise to pay attention as the company announces its latest results.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Renowned health benefits provider UnitedHealth Group (UNH - Free Report) is set to report quarterly results Friday before the opening bell. UnitedHealth Group, a Zacks Rank #3 (Hold), has a robust history of exceeding earnings estimates. But as stocks have been volatile lately, is this market leader a buy heading into the Q2 earnings announcement?
Shares of UNH are up 1.37% this year, widely outperforming the major indices. Analysts are expecting the company to post Q2 EPS of $5.24 per share, which would translate to 11.49% growth versus the same quarter last year.
UnitedHealth Group has surpassed earnings estimates in every quarter for the past five years running. This long string of success suggests another earnings beat may be in store for investors. UNH has delivered a trailing four-quarter average earnings beat of 3.73%.
UNH is part of the Zacks Medical – HMOs industry, which ranks in the top 26% out of approximately 250 industry groups. The company pays a $6.60 (1.32%) annual dividend. UNH stock has really held up well this year while the market has corrected, and investors would be wise to pay attention as the company announces its latest results.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on UNH - FREE